Subscribe
Supporting Early Stage Immunotherapy Research to Fuel Breakthroughs in Cancer Treatment: Jill O’Donnell-Tormey, Ph.D., CEO & Director of Scientific Affairs, Cancer Research Institute

The Real Chemistry Podcast

Supporting Early Stage Immunotherapy Research to Fuel Breakthroughs in Cancer Treatment: Jill O’Donnell-Tormey, Ph.D., CEO & Director of Scientific Affairs, Cancer Research Institute

Cancer Research Institute is a pioneer in using immunotherapy to treat cancer. This week’s guest, Jill O’Donnell-Tormey, Ph.D., CEO and Director of Scientific Affairs, discusses the future of oncology research,…
October 18, 2018

Supporting Early Stage Immunotherapy Research to Fuel Breakthroughs in Cancer Treatment: Jill O’Donnell-Tormey, Ph.D., CEO & Director of Scientific Affairs, Cancer Research Institute

Cancer Research Institute is a pioneer in using immunotherapy to treat cancer. This week’s guest, Jill O’Donnell-Tormey, Ph.D., CEO and Director of Scientific Affairs, discusses the future of oncology research, the upcoming CRI Awards Gala, what it’s like working alongside a Nobel Prize winner, and her love of baking.

 

Listen on your favorite player

New to Podcasts? It's easy to get started!

You may also like

Subscribe to Health Podcast Network and never miss new Episodes!

Proudly supported by:

cover
Y’all Means All Communities are powered by people—and the variety of lives, jobs, schedules, and skills keep cities buzzing. Providing care means healthcare has to show up for "y’all" no matter the gender identity, work schedule, or preferred language.